Mmbg Investment Advisors Co. Astrazeneca PLC Transaction History
Mmbg Investment Advisors Co.
- $941 Million
- Q4 2024
A detailed history of Mmbg Investment Advisors Co. transactions in Astrazeneca PLC stock. As of the latest transaction made, Mmbg Investment Advisors Co. holds 7,459 shares of AZN stock, worth $548,236. This represents 0.05% of its overall portfolio holdings.
Number of Shares
7,459
Previous 5,809
28.4%
Holding current value
$548,236
Previous $452,000
7.96%
% of portfolio
0.05%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,367Shares Held
475MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.44 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.01 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.76 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.77 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.43 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $228B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...